Published on 5/21/2015 in the Prospect News Structured Products Daily.
New Issue: JPMorgan prices $2 million one-year digital notes on Juno Therapeutics
By Susanna Moon
Chicago, May 21 – JPMorgan Chase & Co. priced $2 million of 0% digital notes due June 8, 2016 linked to Juno Therapeutics, Inc. shares, according to a 424B2 filing with the Securities and Exchange Commission.
If the stock finishes at or above the 50% barrier level, the payout at maturity will be par plus the digital return of 14.45%.
Otherwise, investors will be fully exposed to any losses.
J.P. Morgan Securities LLC is the agent.
| Issuer: | JPMorgan Chase & Co.
|
| Issue: | Digital notes
|
| Underlying stock: | Juno Therapeutics, Inc. (Symbol: JUNO)
|
| Amount: | $2 million
|
| Maturity: | June 8, 2016
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | If stock finishes at or above 50% barrier level, par plus 14.45%; otherwise, full exposure to any losses
|
| Initial level: | $45.44
|
| Barrier level: | 50% of initial level
|
| Pricing date: | May 19
|
| Settlement date: | May 22
|
| Agent: | J.P. Morgan Securities LLC
|
| Fees: | 1%
|
| Cusip: | 48125USP8
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
